Concepedia

Jianxin Feng

JF

Statistics

Publications

4

Citations

108

H-Index

4

Active since

2012

Affiliations

Bristol-Myers Squibb (United States)(Current)

Jianxin Feng is an author at Bristol-Myers Squibb (United States) specializing in medicinal chemistry, pharmacology, and pharmacy.

Publications per year

2012–2022

4

Publications

4

Optimization of Activity, Selectivity, and Liability Profiles in 5-Oxopyrrolopyridine DPP4 Inhibitors Leading to Clinical Candidate (<i>Sa</i>)-2-(3-(Aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl-5-oxo-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridin-6(7<i>H</i>)-yl)-<i>N</i>,<i>N</i>-dimethylacetamide (BMS-767778)

Pratik Devasthale, Ying Wang, Wei Wang et al. · Journal of Medicinal Chemistry · 2013 · 45 citations · Full text

, , +16

Identification of Monosaccharide Derivatives as Potent, Selective, and Orally Bioavailable Inhibitors of Human and Mouse Galectin-3

Chunjian Liu, Prasada Rao Jalagam, Jianxin Feng et al. · Journal of Medicinal Chemistry · 2022 · 31 citations · Full text

, , +12

Utilization of an Active Site Mutant Receptor for the Identification of Potent and Selective Atypical 5-HT<sub>2C</sub>Receptor Agonists

Joseph Carpenter, Ying Wang, Gang Wu et al. · Journal of Medicinal Chemistry · 2017 · 17 citations · Full text

, , +17

Synthesis and SAR of 2,3,3a,4-tetrahydro-1H-pyrrolo[3,4-c]isoquinolin-5(9bH)-ones as 5-HT2C receptor agonists

John M. Fevig, Jianxin Feng, Karen A. Rossi et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 15 citations · Full text

, , +11

1–4 of 4